Stryker Corp (SYK)
325.45
-2.00
(-0.61%)
USD |
NYSE |
Apr 19, 16:00
325.45
0.00 (0.00%)
After-Hours: 16:42
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 123.76B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 13.70% |
| Valuation | |
| PE Ratio | 39.45 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 6.092 |
| Price to Book Value | 6.656 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.80 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.6989 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 43.80% |
Profile
| Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States. |
| URL | https://www.stryker.com |
| Investor Relations URL | https://investors.stryker.com |
| HQ State/Province | Michigan |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Apr. 30, 2024 |
| Last Earnings Release | Jan. 30, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 27, 2024 |
Ratings
Profile
| Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States. |
| URL | https://www.stryker.com |
| Investor Relations URL | https://investors.stryker.com |
| HQ State/Province | Michigan |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Apr. 30, 2024 |
| Last Earnings Release | Jan. 30, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 27, 2024 |